Suzhou Zelgen Biopharmaceuticals Co Ltd banner

Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 93.33 CNY 1.89% Market Closed
Market Cap: ¥24.7B

Suzhou Zelgen Biopharmaceuticals Co Ltd
Investor Relations

Nestled within the bustling cityscape of Suzhou, Suzhou Zelgen Biopharmaceuticals Co Ltd stands as a testament to China's burgeoning biopharmaceutical industry. Founded with a visionary zeal, the company has carved out a niche in the highly specialized world of biotherapeutics, focusing on the development, production, and commercialization of innovative drugs. Its strategic direction is underpinned by a robust commitment to addressing unmet medical needs, particularly in the fields of oncology, hepatology, and orthodox therapeutics. Zelgen thrives in a highly competitive industry by maintaining a dynamic pipeline of drug candidates at various stages of clinical trials, leveraging cutting-edge biotechnology to develop next-generation treatments.

The financial lifeline of Suzhou Zelgen Biopharmaceuticals lies in its strategic ability to transform scientific innovation into commercial success. Revenue streams are primarily generated through the successful launch of their proprietary drugs, supported by effective marketing and distribution channels in key global markets. Alliances and partnerships further augment their financial ecosystem, enabling the confluence of research advancements and technology transfers. The company’s ability to monetize its research breakthroughs not only fuels its growth but also assures its stakeholders of its enduring commitment to delivering value, both in terms of health benefits and shareholder returns. By continually expanding its capabilities in biologics manufacturing and regulatory affairs, Zelgen captures significant market opportunities, propelling the company forward in an ever-evolving industry landscape.

Show more
Loading
688266
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Zelin Sheng
Chairman of the Board & GM
No Bio Available
Mr. Gang Huang
CFO & Deputy GM
No Bio Available
Ms. Zeqi Sheng
Chief Scientific Officer
No Bio Available
Ms. Huiping Lu
Executive VP & Director
No Bio Available
Mr. Jisheng Wu
Director & Deputy GM
No Bio Available
Mr. Binhua Lv
Deputy General Manager & Director
No Bio Available
Ms. Qingping Gao
Deputy GM & Board Secretary
No Bio Available

Contacts

Address
JIANGSU
Suzhou
No. 262, Chenfeng Road, Yushan Town, Kunshan City
Contacts
+8651257018310
www.zelgen.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett